STOCK TITAN

Point72 discloses 5% Neuronetics (STIM) stake in new SEC ownership filing

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen report beneficial ownership of common stock of Neuronetics, Inc. The filing covers 3,822,124 shares of common stock, representing 5.0% of the class as of the close of business on August 13, 2026. The reporting persons hold no sole voting or dispositive power, but have shared voting and shared dispositive power over all 3,822,124 shares. The shares are held by Point72 Associates, LLC, an investment fund managed by Point72 Asset Management, under an investment management agreement. The reporting persons state that the filing should not be construed as an admission that any of them is the beneficial owner of these shares for purposes of Section 13 of the Securities Exchange Act.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 3,822,124 shares Common stock of Neuronetics, Inc. as of close of business on August 13, 2026
Percent of class 5.0% Portion of Neuronetics, Inc. common stock class reported as beneficially owned
Shared voting power 3,822,124 shares Shares over which the reporting persons have shared power to vote or direct the vote
Shared dispositive power 3,822,124 shares Shares over which the reporting persons have shared power to dispose or direct disposition
Reporting date August 13, 2026 Date as of which ownership, voting, and dispositive information is stated
beneficial owner financial
"the beneficial owner of the Shares reported herein"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
shared voting power financial
"Shared Voting Power 3,822,124.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared Dispositive Power 3,822,124.00"
investment management agreement financial
"Pursuant to an investment management agreement, Point72 Asset Management"
An investment management agreement is a written contract that hires a professional to make buying, selling and strategy decisions for an investment account or fund, and sets out their duties, fees, risk limits, performance measures and reporting requirements. It matters to investors because the agreement determines who controls the money, how much the service costs, what risks are allowed, and how success or failure is measured—think of it as the service contract that defines expectations and remedies for a hired portfolio manager.
Schedule 13G regulatory
"agreed to file this jointly in accordance with the provisions of Rule 13d-1(k)"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

What percentage of Neuronetics, Inc. (STIM) does Point72 report owning?

Point72 reports beneficial ownership of 5.0% of Neuronetics, Inc. common stock. This stake corresponds to 3,822,124 shares of common stock as of the close of business on August 13, 2026.

How many Neuronetics (STIM) shares are reported as beneficially owned by Point72?

The filing reports beneficial ownership of 3,822,124 shares of Neuronetics common stock. These shares are held by Point72 Associates, LLC, with investment and voting power maintained by Point72 Asset Management under an investment management agreement.

Who are the reporting persons in the Neuronetics (STIM) Schedule 13G?

The reporting persons are Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen. They file jointly under a Joint Filing Agreement regarding their beneficial ownership of Neuronetics common stock.

What voting power does Point72 report over its Neuronetics (STIM) holdings?

The reporting persons disclose 0 shares with sole voting power and 3,822,124 shares with shared voting power. They also report the same 3,822,124 shares with shared dispositive power and no sole dispositive power.

Which entity has the right to dividends or sale proceeds from the Neuronetics (STIM) shares?

The filing states that Point72 Associates, LLC has the right to receive, or direct the receipt of, dividends and sale proceeds from more than 5 percent of Neuronetics’ outstanding common shares reported in this statement.

As of what date is Point72’s Neuronetics (STIM) ownership information reported?

The ownership information, including the 3,822,124 shares and 5.0% stake, is stated to be accurate as of the close of business on August 13, 2026. All voting and dispositive power details are tied to this same date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





64131A105

(CUSIP Number)
08/13/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Point72 Asset Management, L.P.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:08/14/2026
Point72 Capital Advisors, Inc.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:08/14/2026
Steven A. Cohen
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:08/14/2026
Exhibit Information

Exhibit 99.1: Joint Filing Agreement